Latest Breaking News On - John mullalylifesci advisors - Page 1 : comparemela.com

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thierry guillaudeuxShawn iadonatoJohn mullalylifesci advisorsJacques bouchyevp investor relations business developmentKineta incTherapy against poorly immunogenicHighly potentNew immune checkpoint inhibitorPromising therapy against poorly immunogenicChief scientific officerChief executive officerStatements regarding forward lookingPrivate securities litigation reform actAnnual reportQuarterly reports

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThierry guillaudeuxKineta incJacques bouchyevp investor relations business developmentJohn mullalylifesci advisorsAnnual macrophage directed therapies summitChief scientific officerEngineered iggCombination with pembrolizumabAdvanced solid tumorspresenterBusiness development

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn iadonatoThierry guillaudeuxJacques bouchyevp investor relations business developmentSociety for immunotherapy of cancerKineta incSan diego convention centerJohn mullalylifesci advisorsFavorable clinical safetyTolerability profile observedCombination therapy clinical data anticipatedChief scientific officerChief executive officerAbstract numberTime locationExhibit hallsDiego convention

Kineta Announces Participation at October Investor Conferences

Kineta Announces Participation at October Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoGroup family office private wealth management forumKineta incJohn mullalylifesci advisorsJacques bouchyevp investor relations business developmentSummit formatFamily officePrivate wealth management forum westBusiness development

Kineta Set to Join Russell Microcap® Index

Kineta Set to Join Russell Microcap® Index
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomShawn iadonatoJacques bouchyevp investor relations business developmentKineta incLondon stock exchange groupJohn mullalylifesci advisorsRussell microcapChief executive officerLondon stock exchangeStatements regarding forward lookingPrivate securities litigation reform actAnnual reportQuarterly reportBusiness development